Journal of Lipid Research, Vol 32, 125-136, Copyright © 1991 by Lipid Research, Inc.

ARTICLES

Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures

AK Gupta and H Rudney
Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, OH 45267-0524.

We have examined the mechanism of the inhibition of cholesterol synthesis in cells treated with exogenous sphingomyelinase. Treatment of rat intestinal epithelial cells (IEC-6), human skin fibroblasts (GM- 43), and human hepatoma (HepG2) cells in culture with sphingomyelinase resulted in a concentration- and time-dependent inhibition of the activity of HMG-CoA reductase, a key regulatory enzyme in cholesterol biosynthesis. The following observations were obtained with IEC-6 cells. Free fatty acid synthesis or general cellular protein synthesis was unaffected by the addition of sphingomyelinase. Addition of sphingomyelinase to the in vitro reductase assay had no effect on activity, suggesting that an intact cell system is required for the action of sphingomyelinase. The products of sphingomyelin hydrolysis, e.g., ceramide and phosphocholine, had no effect on reductase activity. Sphingosine, a further product of ceramide metabolism, caused a stimulation of reductase activity. Examination of the incorporation of [3H]acetate into the nonsaponifiable lipid fractions in the presence of sphingomyelinase showed no changes in the percent distribution of radioactivity in the post-mevalonate intermediates of the cholesterol biosynthetic pathway, but there was increased radioactivity associated with the polar sterol fraction. Pretreatment of cells with ketoconazole, a known inhibitor of oxysterol formation, prevented the inhibition of reductase activity by sphingomyelinase and decreased the incorporation of [3H]acetate in the polar sterol fraction. Ketoconazole had no effect on exogenous sphingomyelinase activity in vitro in the presence or absence of cells. Endogenous sphingomyelinase activity was also unaffected by ketoconazole. Addition of inhibitors of endogenous sphingomyelinase activity, e.g., chlorpromazine, desipramine, and N-(6- aminohexyl)-5-chloro-1-naphthalene sulfonamide (W-7), to the culture medium caused a dose-dependent stimulation of reductase activity. However, these agents had no effect on the inhibition of reductase activity by exogenous sphingomyelinase. Treatment of cells with small unilamellar vesicles of dioleyl phosphatidylcholine or high density lipoprotein3 resulted in increased efflux of cholesterol and stimulation of reductase activity. Under similar conditions, the inhibitory effect of exogenous sphingomyelinase on reductase activity was prevented by incubation with small unilamellar vesicles of phosphatidylcholine or high density lipoprotein. These results support the hypothesis that alteration of the ratio of sphingomyelin:cholesterol in the plasma membrane plays a modulatory role on the flow of membrane cholesterol to a site where it may be converted to a putative regulatory molecule, possibly an oxysterol.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Klingenberg, J.-R. Nofer, M. Rudling, F. Bea, E. Blessing, M. Preusch, H. J. Grone, H. A. Katus, G. K. Hansson, and T. J. Dengler Sphingosine-1-Phosphate Analogue FTY720 Causes Lymphocyte Redistribution and Hypercholesterolemia in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2392 - 2399. [Abstract] [Full Text] [PDF]

				K. Ma, R. Langenbach, S. I. Rapoport, and M. Basselin Altered brain lipid composition in cyclooxygenase-2 knockout mouse J. Lipid Res., April 1, 2007; 48(4): 848 - 854. [Abstract] [Full Text] [PDF]

				Y. Lange, J. Ye, and T. L. Steck Activation of Membrane Cholesterol by Displacement from Phospholipids J. Biol. Chem., October 28, 2005; 280(43): 36126 - 36131. [Abstract] [Full Text] [PDF]

				J. M. Holopainen, A. J. Metso, J.-P. Mattila, A. Jutila, and P. K. J. Kinnunen Evidence for the Lack of a Specific Interaction between Cholesterol and Sphingomyelin Biophys. J., March 1, 2004; 86(3): 1510 - 1520. [Abstract] [Full Text] [PDF]

				C. M. Adams, J. L. Goldstein, and M. S. Brown Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphiles PNAS, September 16, 2003; 100(19): 10647 - 10652. [Abstract] [Full Text] [PDF]

				D. Y. Hui and P. N. Howles Carboxyl ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis J. Lipid Res., December 1, 2002; 43(12): 2017 - 2030. [Abstract] [Full Text] [PDF]

				J.-i. Ito, Y. Nagayasu, S. Ueno, and S. Yokoyama Apolipoprotein-mediated Cellular Lipid Release Requires Replenishment of Sphingomyelin in a Phosphatidylcholine-specific Phospholipase C-dependent Manner J. Biol. Chem., November 15, 2002; 277(47): 44709 - 44714. [Abstract] [Full Text] [PDF]

				T. S. Worgall, R. A. Johnson, T. Seo, H. Gierens, and R. J. Deckelbaum Unsaturated Fatty Acid-mediated Decreases in Sterol Regulatory Element-mediated Gene Transcription Are Linked to Cellular Sphingolipid Metabolism J. Biol. Chem., February 1, 2002; 277(6): 3878 - 3885. [Abstract] [Full Text] [PDF]

				R. J. Kirby, S. Zheng, P. Tso, P. N. Howles, and D. Y. Hui Bile Salt-stimulated Carboxyl Ester Lipase Influences Lipoprotein Assembly and Secretion in Intestine. A PROCESS MEDIATED VIA CERAMIDE HYDROLYSIS J. Biol. Chem., February 1, 2002; 277(6): 4104 - 4109. [Abstract] [Full Text] [PDF]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				H. Vesper, E.-M. Schmelz, M. N. Nikolova-Karakashian, D. L. Dillehay, D. V. Lynch, and A. H. Merrill Jr. Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition J. Nutr., July 1, 1999; 129(7): 1239 - 1250. [Abstract] [Full Text]

				B. A. Bladergroen, A. C. Beynen, and M. J. H. Geelen Dietary Pectin Lowers Sphingomyelin Concentration in VLDL and Raises Hepatic Sphingomyelinase Activity in Rats J. Nutr., March 1, 1999; 129(3): 628 - 633. [Abstract] [Full Text]

				T. A. Lagace, D. M. Byers, H. W. Cook, and N. D. Ridgway Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol J. Lipid Res., January 1, 1999; 40(1): 109 - 116. [Abstract] [Full Text]

				N. D. Ridgway, T. A. Lagace, H. W. Cook, and D. M. Byers Differential Effects of Sphingomyelin Hydrolysis and Cholesterol Transport on Oxysterol-binding Protein Phosphorylation and Golgi Localization J. Biol. Chem., November 20, 1998; 273(47): 31621 - 31628. [Abstract] [Full Text] [PDF]

				I. Arimoto, H. Saito, Y. Kawashima, K. Miyajima, and T. Handa Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions J. Lipid Res., January 1, 1998; 39(1): 143 - 151. [Abstract] [Full Text]

				S. Scheek, M. S. Brown, and J. L. Goldstein Sphingomyelin depletion in cultured cells blocks proteolysis of sterol regulatory element binding proteins at site 1 PNAS, October 14, 1997; 94(21): 11179 - 11183. [Abstract] [Full Text] [PDF]

				P. Debry, E. A. Nash, D. W. Neklason, and J. E. Metherall Role of Multidrug Resistance P-glycoproteins in Cholesterol Esterification J. Biol. Chem., January 10, 1997; 272(2): 1026 - 1031. [Abstract] [Full Text] [PDF]

				P. J. Skiba, X. Zha, F. R. Maxfield, S. L. Schissel, and I. Tabas The Distal Pathway of Lipoprotein-induced Cholesterol Esterification, but Not Sphingomyelinase-induced Cholesterol Esterification, Is Energy-dependent J. Biol. Chem., June 7, 1996; 271(23): 13392 - 13400. [Abstract] [Full Text] [PDF]

				A. Gómez-Muñoz, D. W. Waggoner, L. O'Brien, and D. N. Brindley Interaction of Ceramides, Sphingosine, and Sphingosine 1-Phosphate in Regulating DNA Synthesis and Phospholipase D Activity J. Biol. Chem., November 3, 1995; 270(44): 26318 - 26325. [Abstract] [Full Text] [PDF]

				I. Maor, H. Mandel, and M. Aviram Macrophage Uptake of Oxidized LDL Inhibits Lysosomal Sphingomyelinase, Thus Causing the Accumulation of Unesterified Cholesterol–Sphingomyelin–Rich Particles in the Lysosomes : A Possible Role for 7-Ketocholesterol Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1378 - 1387. [Abstract] [Full Text]

				M. Fukasawa, M. Nishijima, H. Itabe, T. Takano, and K. Hanada Reduction of Sphingomyelin Level without Accumulation of Ceramide in Chinese Hamster Ovary Cells Affects Detergent-resistant Membrane Domains and Enhances Cellular Cholesterol Efflux to Methyl-beta -cyclodextrin J. Biol. Chem., October 27, 2000; 275(44): 34028 - 34034. [Abstract] [Full Text] [PDF]